Grifols, S.A. (GIKLY) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-05 16:11:15 ET
Grifols, S.A. (GIKLY) Q3 2025 Earnings Call November 4, 2025 12:30 PM EST
Company Participants
Daniel Segarra - Head of Investor Relations & Sustainability and Vice President
Jose Ignacio Abia Buenache - CEO & Director
Roland Wandeler - President of Biopharma Business Unit
Rahul Srinivasan - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Grifols, S.A. (GIKLY) Q3 2025 Earnings Call Transcript
Grifols SA Barcelona
NASDAQ: GIFLF
GIFLF Trading
2.98% G/L:
$12.90 Last:
2,400 Volume:
$12.527 Open:
GIFLF Latest News
March 17, 2026 08:28:35 am
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease
January 14, 2025 06:00:00 am
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease
GIFLF Stock Data
$6,586,776,019
559,676,571
N/A
69
N/A
Pharmaceuticals
Healthcare
ES
Sant Cugat del Valles
